Adverse Effects

Contributing journals to this collection:
JAMA & Archives Journals

Citations 331-340 of 1622 total displayed.

Past content

Images in Neurology
Leflunomide-Associated Progressive Multifocal Leukoencephalopathy

Megan Rahmlow; Elizabeth A. Shuster; Jacob Dominik; H. Gordon Deen Jr; Dennis W. Dickson; Allen J. Aksamit Jr; Hector A. Robles; William D. Freeman
Arch Neurol 2008; 65: 1538-1539. [Extract] [Full text] [PDF]  

Research Letters
Peripheral Iridoplasty Efficacy in Refractory Topiramate-Associated Bilateral Acute Angle-Closure Glaucoma

Alan H. Zalta; Ryan T. Smith
Arch Ophthalmol 2008; 126: 1603-1605. [Extract] [Full text] [PDF]  

Research Letters
Cystoid Macular Edema Secondary to Albumin-Bound Paclitaxel Therapy

Stacy V. Smith; Matthew S. Benz; David M. Brown
Arch Ophthalmol 2008; 126: 1605-1606. [Extract] [Full text] [PDF]  

Editorials
Glycemic Management of Type 2 Diabetes: How Tight Is Right and How to Get There

David M. Nathan
Arch Intern Med 2008; 168: 2064-2066. [Extract] [Full text] [PDF]  

Review Articles
Cardiovascular Outcomes in Trials of Oral Diabetes Medications: A Systematic Review

Elizabeth Selvin; Shari Bolen; Hsin-Chieh Yeh; Crystal Wiley; Lisa M. Wilson; Spyridon S. Marinopoulos; Leonard Feldman; Jason Vassy; Renee Wilson; Eric B. Bass; Frederick L. Brancati
Arch Intern Med 2008; 168: 2070-2080. [Abstract] [Full text] [PDF]  

Editor's Correspondence
Heparin and Thrombocytopenia: Guilty Till Proven Innocent?

Harris V. K. Naina; Samar Harris
Arch Intern Med 2008; 168: 2169-a-2170-a. [Extract] [Full text] [PDF]  

Editor's Correspondence
Risk Factors for Thrombocytopenia in Patients Treated With Prolonged Heparin Therapy

David R. Williamson; Danielle Pilon
Arch Intern Med 2008; 168: 2170-a-2171-a. [Extract] [Full text] [PDF]  

Editor's Correspondence
Incidence and Prognostic Significance of Thrombocytopenia in Patients Receiving Heparin Therapy

Weekitt Kittisupamongkol
Arch Intern Med 2008; 168: 2170. [Extract] [Full text] [PDF]  

Editor's Correspondence
Risk Factors for Thrombocytopenia in Patients Treated With Prolonged Heparin Therapy—Reply

Christopher B. Granger; E. Magnus Ohman; Richard C. Becker
Arch Intern Med 2008; 168: 2171. [Extract] [Full text] [PDF]  

Original Contributions
Safety-Related Regulatory Actions for Biologicals Approved in the United States and the European Union

Thijs J. Giezen; Aukje K. Mantel-Teeuwisse; Sabine M. J. M. Straus; Huub Schellekens; Hubert G. M. Leufkens; Antoine C. G. Egberts
JAMA 2008; 300: 1887-1896. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163